Yes, R-CHOP can cure DLBCL for many people! It's the standard first-line treatment, and the numbers are encouraging.
Here's what the data shows:
- 60%β70% of newly diagnosed DLBCL cases are cured with R-CHOP
- More than 3 out of 4 people reach complete remission after R-CHOP
- For relapsed cases, R-CHOP still works for Show Full Answer
Yes, R-CHOP can cure DLBCL for many people! It's the standard first-line treatment, and the numbers are encouraging.
Here's what the data shows:
- 60%β70% of newly diagnosed DLBCL cases are cured with R-CHOP
- More than 3 out of 4 people reach complete remission after R-CHOP
- For relapsed cases, R-CHOP still works for about 30%β40% of people For high-risk or advanced DLBCL, there are additional options that can improve outcomes. Here's what to discuss with your oncologist:
- Pola-R-CHP β FDA-approved in 2023 as a first-line option, it delivers chemotherapy directly to lymphoma cells using an antibody-drug conjugate
- CAR T-cell therapy β A newer immunotherapy that engineers your own T-cells to fight lymphoma, used when DLBCL returns after first-line treatment
- Bone marrow transplant β An option if DLBCL relapses after treatment
- R-EPOCH β A more aggressive regimen sometimes used for certain high-risk subtypes
The most important step is talking openly with your oncologist about your specific risk factors, stage, and treatment history to find the best path forward.
September 8